E-LIB Suche - Ergebnisse für: Decaux, O.

1

French early nationwide idecabtagene vicleucel chimeric ant..:

Ferment, B. ; Lambert, J. ; Caillot, D....
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

2

Remote monitoring of CAR T‐cell treated patients by a speci..:

Colin, F. ; Bellec, A. ; Le Bars, L....
Hematological Oncology. 41 (2023) S2 - p. 542-542 , 2023

Link: https://doi.org/10.1002/..

3

B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS:..:

Roussel, M. ; Pirotte, M. ; Gounot, R....
HemaSphere. 7 (2023) S2 - p. 4-4 , 2023

Link: https://doi.org/10.1097/..

4

P929: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I-DAR..:

Macro, M. ; Touzeau, C. ; Mariette, C....
HemaSphere. 6 (2022) - p. 819-820 , 2022

Link: https://doi.org/10.1097/..

5

P956: EMMY COHORT: MANAGEMENT OF NEWLY DIAGNOSED OR RELAPSE..:

Macro, M. ; Decaux, O. ; Perrot, A....
HemaSphere. 6 (2022) - p. 846-847 , 2022

Link: https://doi.org/10.1097/..

6

P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WOR..:

Decaux, O. ; Hulin, C. ; Perrot, A....
HemaSphere. 6 (2022) - p. 795-796 , 2022

Link: https://doi.org/10.1097/..

7

P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA P..:

Hulin, C. ; Macro, M. ; Perrot, A....
HemaSphere. 6 (2022) - p. 845-846 , 2022

Link: https://doi.org/10.1097/..

8

S176: DARATUMUMAB CARFILZOMIB LENALIDOMIDE AND DEXAMETHASON..:

Touzeau, C. ; Perrrot, A. ; Hulin, C....
HemaSphere. 6 (2022) - p. 77-78 , 2022

Link: https://doi.org/10.1097/..

9

POSB404 Therapeutic Management of Multiple Myeloma and Heal..:

Decaux, O ; Frenzel, L ; Royer, B...
Value in Health. 25 (2022) 1 - p. S259-S260 , 2022

Link: https://doi.org/10.1016/..

10

P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RE..:

Bobin, A. ; Manier, S. ; De Keizer, J....
HemaSphere. 6 (2022) - p. 783-784 , 2022

Link: https://doi.org/10.1097/..

11

Cessation of oral anticoagulants in antiphospholipid syndro..:

Comarmond, C ; Jego, P ; Veyssier-Belot, C...
Lupus. 26 (2017) 12 - p. 1291-1296 , 2017

Link: https://doi.org/10.1177/..

12

Benefit of continuous treatment for responders with newly d..:

Bahlis, N J ; Corso, A ; Mugge, L-O...
Leukemia. 31 (2017) 11 - p. 2435-2442 , 2017

Link: https://doi.org/10.1038/..

13

35 SYSTEMIC INFLAMMATORY AND AUTOIMMUNE DISEASES (SAID) ASS..:

Mekinian, A. ; Grignano, E. ; Braun, T....
Leukemia Research. 39 (2015) - p. S15-S16 , 2015

Link: https://doi.org/10.1016/..

14

Heavy/light chain specific immunoglobulin ratios provides n..:

Beaumont-Epinette, M.-P. ; Moreau, C. ; Besnard, S....
Pathologie Biologie. 63 (2015) 4-5 - p. 215-221 , 2015

Link: https://doi.org/10.1016/..

15

Use of protein-to-creatinine ratio in spot urine samples fo..:

Le Mouel, E. ; Frouget, T. ; Collet, N...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e255 , 2015

Link: https://doi.org/10.1016/..